Transforming growth factor-beta(1) modifies fibroblast growth factor-2 production in type II cells

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Biochemistry

Background:

• Transforming growth factor-beta(1) (TGF-β1) is an inflammatory cytokine involved in pulmonary fibrosis.
• Fibroblast growth factor-2 (FGF-2) is a potent mitogen for type II lung cells.
• TGF-β1 influences FGF-2 production in vascular endothelium, suggesting a role in lung repair.

Purpose of the Study:

• To investigate if TGF-β1 or FGF-1 modulate FGF-2 production in isolated rat alveolar type II cells.
• To examine the effect of extracellular matrix components, specifically heparin, on these interactions.

Main Methods:

• Isolated rat type II cells were treated with varying concentrations of TGF-β1 or FGF-1 for 1-3 days.
• FGF-2 protein levels were quantified using a specific immunoassay.
• Messenger RNA (mRNA) expression for FGF-2 and FGF receptor (FGFR)-1 was analyzed.
• The impact of heparin on these molecular changes was assessed.

Main Results:

• Both TGF-β1 and FGF-1 significantly increased FGF-2 protein and mRNA levels in type II cells.
• Transcripts for FGFR-1 were also upregulated by TGF-β1 and FGF-1.
• Heparin significantly downregulated the expression of TGF-β1 and FGF-1-stimulated FGF-2 and FGFR-1.

Conclusions:

• TGF-β1 and FGF-1 play a regulatory role in FGF-2 production by alveolar type II cells.
• Sulfated extracellular matrix components, like heparin, can modulate these growth factor interactions.
• These findings highlight potential mechanisms contributing to lung repair and fibrosis development.